메뉴 건너뛰기




Volumn 35, Issue 2, 2005, Pages 213-214

Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis [7]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANAGRELIDE; ANTIHISTAMINIC AGENT; AZATHIOPRINE; COMPLEMENT COMPONENT C1S INHIBITOR; CYCLOSPORIN A; FLUDARABINE; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEINASE INHIBITOR; STANOZOLOL;

EID: 13244255432     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704748     Document Type: Letter
Times cited : (5)

References (4)
  • 3
    • 0025719573 scopus 로고
    • C1 inhibitor deficiency: Molecular and immunologic basis of hereditary and acquired angioedema
    • Oltvai ZN, Wong EC, Atkinson JP, Tung KS. C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 1991; 65: 381-388.
    • (1991) Lab. Invest. , vol.65 , pp. 381-388
    • Oltvai, Z.N.1    Wong, E.C.2    Atkinson, J.P.3    Tung, K.S.4
  • 4
    • 0142243116 scopus 로고    scopus 로고
    • Clinical and biological distinction between type I and type II acquired angioedema
    • Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C. Clinical and biological distinction between type I and type II acquired angioedema. Am J Med 2003; 115: 420-421.
    • (2003) Am. J. Med. , vol.115 , pp. 420-421
    • Bouillet-Claveyrolas, L.1    Ponard, D.2    Drouet, C.3    Massot, C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.